Visiting Professor. Kellogg School of Management, Center for Biotechnology. January 2006 – present.

Research supervisor. ETLA, The Research Institute of the Finnish Economy, Finland. Industrial Economics and International Business program: Managerial Economics of Biotechnology. January 2002 – present.

Research economist. ETLA, The Research Institute of the Finnish Economy, Finland. Forecasting unit. August 2000 – December 2003.

Researcher. Helsinki University of Technology, Institute for Regional Economics and Business Strategies, Finland. May 1998 – August 2000.

“Sustainable biotechnology development” with Martti Kulvik

“Biological technology as a competitive edge for the Finnish forest cluster” with several colleagues

“Specialization and location of the Finnish biotechnology industry” with Antti Tahvanainen

“How do governmentally financed biotechnology ventures differ from their private counterparts?”

“Managerial views on the growth prospects of the Finnish biotechnology industry” with Tomi Hussi and Martti Kulvik.

“Valuation of patent citations” with Tuomo Nikulainen and Martti Kulvik.

“Technology adoption and health care costs” with Martti Kulvik and Ismo Linnosmaa.

“R&D inputs and price-cost margins in the Finnish and US pharmaceutical industry” with Ismo Linnosmaa.

“New economic geography of European regions”

“Projected Growth Effects of the Biotechnology Industry in Finland: The Fourth Pillar of the Economy?”(with Martti Kulvik). International Journal of Biotechnology, 2005, vol. 7, no. 4, 269-287.

“Funding Intellectual-Capital-Abundant Technology Development: Empirical Evidence from the Finnish Biotechnology Business” (with Antti-Jussi Tahvanainen). Knowledge Management Research & Practice, 2005, vol. 3, no. 2, 69-86.

“Value Creation Potential of Intellectual Capital in Biotechnology: Empirical Evidence from Finland” (with Ilkka Kauranen). R&D Management, 2005, vol. 35, 171-185.

“International Mega-trends and Growth Prospects of the Finnish Biotechnology Industry: Recent Economic Research and Policy Implications” (with Martti Kulvik and Pekka Ylä-Anttila). Journal of Commercial Biotechnology, 2005, vol. 11, no. 2, 134-145.

“Measuring intellectual capital and sources of equity financing – value platform perspective within the Finnish biopharmaceutical industry” (with Martti Kulvik). International Journal of Learning and Intellectual Capital, 2004, vol. 1, no. 3, 282-303.

“Price-cost Margin in the Pharmaceutical Industry - Empirical Evidence from Finland” (with Ismo Linnosmaa and Taru Hallinen). The European Journal of Health Economics, 2004, vol.5, no. 2, 122-128.